Form 8-K - Current report:
SEC Accession No. 0001193125-23-229770
Filing Date
2023-09-06
Accepted
2023-09-06 17:30:04
Documents
16
Period of Report
2023-09-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d547838d8k.htm   iXBRL 8-K 31217
2 EX-99.1 d547838dex991.htm EX-99.1 173519
3 EX-99.2 d547838dex992.htm EX-99.2 191702
4 EX-99.3 d547838dex993.htm EX-99.3 280834
8 GRAPHIC g548500g65g07.jpg GRAPHIC 6629
  Complete submission text file 0001193125-23-229770.txt   877235

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bhc-20230906.xsd EX-101.SCH 2524
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20230906_lab.xml EX-101.LAB 17943
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20230906_pre.xml EX-101.PRE 11234
10 EXTRACTED XBRL INSTANCE DOCUMENT d547838d8k_htm.xml XML 3442
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 231240278
SIC: 2834 Pharmaceutical Preparations